Tata Mid Cap Fund

A Mid Cap Fund scheme from Tata Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF277K01PY2).

NAV ₹534.0824 on 16 November 2026.

Expense ratio

Total expense ratio 0.84% a year for the Direct · Growth plan, as AMFI published it on 28 October 2026: base expense ratio 0.55%, brokerage 0.06%, transaction costs 0.00%, statutory levies including GST 0.23%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year4.0%16.0%-13.0%-0.19-0.19
3 years14.4%15.8%-21.2%0.470.41
5 years14.1%15.6%-21.2%0.450.40
10 years17.8%16.6%-35.1%0.650.57

Category rank: 23rd of 29 Direct-Growth funds in Mid Cap Fund, by 3-year Sortino ratio.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 96.0% of the portfolio.

  1. Mankind Pharma Limited — 3.49%
  2. Bharti Hexacom Limited — 3.15%
  3. One 97 Communications Limited — 3.15%
  4. Bharat Heavy Electricals Limited — 3.07%
  5. Multi Commodity Exchange of India Limited — 2.93%
  6. IndusInd Bank Limited — 2.79%
  7. L&T Finance Limited — 2.78%
  8. Marico Limited — 2.66%
  9. Max Healthcare Institute Limited — 2.61%
  10. AU Small Finance Bank Limited — 2.57%

Plans

Other funds in Mid Cap Fund

All 34 funds in Mid Cap Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.